The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Open accessAbstract
Mitochondrial metabolism provides precursors to build macromolecules in growing cancer cells. In normally functioning tumour cell mitochondria, oxidative metabolism of glucose- and glutamine-derived carbon produces citrate and acetyl-coenzyme A for lipid synthesis, which is required for tumorigenesis. Yet some tumours harbour mutations in the citric acid cycle (CAC) or electron transport chain (ETC) that disable normal oxidative mitochondrial function, and it is unknown how cells from such tumours generate precursors for macromolecular synthesis. Here we show that tumour cells with defective mitochondria use glutamine-dependent reductive carboxylation rather than oxidative metabolism as the major pathway of citrate formation. This pathway uses mitochondrial and cytosolic isoforms of NADP(+)/NADPH-dependent isocitrate dehydrogenase, and subsequent metabolism of glutamine-derived citrate provides both the acetyl-coenzyme A for lipid synthesis and the four-carbon intermediates needed to produce the remaining CAC metabolites and related macromolecular precursors. This reductive, glutamine-dependent pathway is the dominant mode of metabolism in rapidly growing malignant cells containing mutations in complex I or complex III of the ETC, in patient-derived renal carcinoma cells with mutations in fumarate hydratase, and in cells with normal mitochondria subjected to acute pharmacological ETC inhibition. Our findings reveal the novel induction of a versatile glutamine-dependent pathway that reverses many of the reactions of the canonical CAC, supports tumour cell growth, and explains how cells generate pools of CAC intermediates in the face of impaired mitochondrial metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [76]
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [630]
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [123]
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [80]
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [70]
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Mullen et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Branched tricarboxylic acid metabolism in Plasmodium falciparum
Olszewski, K. L., Mather, M. W., Morrisey, J. M., Garcia, B. A., Vaidya, A. B., Rabinowitz, J. D., & Llinás, M. (2010) · Nature · doi:10.1038/nature09301 · Cited by 124
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationGao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,000
Mitochondrial Dysfunction in Gliomas
Katsetos, C. D., Anni, H., & Dráber, P. (2013) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2013.09.003 · Cited by 32
Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
Marchetti, P., Guerreschi, P., Mortier, L., & Kluza, J. (2015) · International Journal of Cell Biology · doi:10.1155/2015/283145 · Cited by 39
Kuo, C., Cheng, C.-T., Hou, P., Lin, Y.-P., Ma, H., Chung, Y., Chi, K. K., Chen, Y., Li, W., Kung, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8570 · Cited by 32
IDH1 deficiency attenuates gluconeogenesis in mouse liver by impairing amino acid utilization
Ye, J., Gu, Y., Zhang, F., Zhao, Y., Yuan, Y., Hao, Z., Sheng, Y., Li, W. Y., Wakeham, A. C., Cairns, R. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618605114 · Cited by 32
An, L., & Li, Z. (2025) · Biomarker Research · doi:10.1186/s40364-025-00844-5 · Cited by 32
Hu, S., Heng, H., Yang, F., Wang, M., Liu, G., Xiang, Y., & Miao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1735873 · Cited by 32
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 31
p53 and regulation of tumor metabolism
Yang, X., Jiang, P., & Du, W. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.122760 · Cited by 32
Toxico‐Metabolomics of Engineered Nanomaterials: Progress and Challenges
Ahmad, F., Wang, X., & Li, W. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904268 · Cited by 31
Prostate Cancer Energetics and Biosynthesis
Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M. A., McGuire, S. E., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_10 · Cited by 33
Carballal, S., Vitvitsky, V., Kumar, R., Hanna, D. A., Libiad, M., Gupta, A., Jones, J. W., & Banerjee, R. V. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100950 · Cited by 34
13C tracer analysis suggests extensive recycling of endogenous CO2 in vivo
Duan, L., Cooper, D. E., Scheidemantle, G. M., Locasale, J. W., Kirsch, D. G., & Liu, X. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00287-8 · Cited by 31
Spatiotemporal Heterogeneity of De Novo Lipogenesis in Fixed and Living Single Cells
Shuster, S. O., Burke, M. J., & Davis, C. M. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c08812 · Cited by 31
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity
Giessner, C., Millet, V., Mostert, K. J., Gensollen, T., Manh, T. V., Garibal, M., Diémé, B., Attaf, N., Chasson, L., Brouilly, N., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800073 · Cited by 33
van der Mijn, J. C., Fu, L., Khani, F., Zhang, T., Molina, A. M., Barbieri, C. E., Chen, Q., Gross, S. S., Gudas, L. J., & Nanus, D. M. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.10.015 · Cited by 31
Renoult, O., Gratas, C., Joalland, N., Laurent—Blond, M., Awada, H., Bourgeois, M., Oliver, L., Chiavassa, S., Croyal, M., Paris, F., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae106 · Cited by 30
Cancer metabolomics in basic science perspective
Kwon, H. N., Oh, S., Jin, X., An, Y., & Park, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0552-4 · Cited by 32
Impact of mitonuclear interactions on life-history responses to diet
Camus, M. F., O'Leary, M., Reuter, M., & Lane, N. J. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0416 · Cited by 30
Different Tumor Microenvironments Lead to Different Metabolic Phenotypes
Antonio, M. J., Zhang, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_10 · Cited by 32
Guo, L.-J., Chen, S., Ou, L., Li, S., Ye, Z.-N., & Liu, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369090 · Cited by 34
Grow₂: the HIF system, energy homeostasis and the cell cycle.
Moniz, S., Biddlestone, J., & Rocha, S. (2014) · PubMed · doi:10.14670/hh-29.10.589 · Cited by 30
Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders?
Kim, A. (2015) · Toxicological Research · doi:10.5487/tr.2015.31.4.323 · Cited by 30
Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling
Yoshikawa, S., Nagao, M., Toh, R., Shinohara, M., Iino, T., Irino, Y., Nishimori, M., Tanaka, H., Satomi‐Kobayashi, S., Ishida, T., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00692.2021 · Cited by 29
Talukdar, P. D., Pramanik, K., Gatti, P., Mukherjee, P., Ghosh, D., Roy, H., Germain, M., & Chatterji, U. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02133-x · Cited by 30
From gametogenesis and stem cells to cancer: common metabolic themes
Pereira, S. L., Rodrigues, A. S., Sousa, M. I., Correia, M., Perestrelo, T., & Ramalho‐Santos, J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu034 · Cited by 33
Brożek-Płuska, B., Kopec, M., Surmacki, J. M., & Abramczyk, H. (2015) · The Analyst · doi:10.1039/c4an01877j · Cited by 29
Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts
Wang, H., Lu, J. L., Kulkarni, S., Zhang, W., Gorka, J. E., Mandel, J. A., Goetzman, E. S., & Prochownik, E. V. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005200 · Cited by 29
Wang, Y., Peng, X., Zhang, M., Jia, Y., Yu, B., & Tian, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9738143 · Cited by 30
Zhu, S., Gu, H., Peng, C. Y., Xia, F., Cao, H., & Cui, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849625 · Cited by 30
Targeting respiratory complex I to prevent the Warburg effect
Vatrinet, R., Iommarini, L., Kurelac, I., Luise, M. D., Gasparre, G., & Porcelli, A. M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.017 · Cited by 31
Eleftheriadis, T., Pissas, G., Yiannaki, E. E., Markala, D., Arampatzis, S., Antoniadi, G., Liakopoulos, V., & Stefanidis, I. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.08.268 · Cited by 29
Cancer Cell Metabolism: There Is No ROS for the Weary
Dang, C. V. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0069 · Cited by 29
Ricoult, S. J. H., Dibble, C. C., Asara, J. M., & Manning, B. D. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00163-16 · Cited by 29
Metabolic modulation during intestinal fibrosis
Bos, S., & Laukens, D. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12882 · Cited by 28
The ER-mitochondria Ca2+ signaling in cancer progression: Fueling the monster
Bustos, G., Ahumada-Castro, U., Silva-Pavez, E., Puebla, A., Lovy, A., & Cárdenas, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.03.006 · Cited by 28
Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas
Ijare, O. B., Hambarde, S., da Costa, F. H. B., Lopez, S., Sharpe, M. A., Helekar, S. A., Hangel, G. J., Bogner, W., Widhalm, G., Bachoo, R. M., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab219 · Cited by 28
Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy
Nair, R., Gupta, P., & Shanmugam, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000106 · Cited by 29
Shi, H., Qi, H., Xie, D., Zhuang, J., Qi, H., Dai, Y., & Wu, J. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.02.003 · Cited by 28
Lu, X., Wu, N., Yang, W., Sun, J., Yan, K., & Wu, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s208848 · Cited by 29
Liu, L., Wang, C.-C., Zhao, X., Guan, J., Lei, C., & Huang, Q. (2019) · Journal of Pest Science · doi:10.1007/s10340-019-01164-y · Cited by 28
Testa, U., Pelosi, E., & Castelli, G. (2020) · Medicines · doi:10.3390/medicines7080044 · Cited by 30
A rapid method for quantifying free and bound acetate based on alkylation and GC-MS analysis
Tumanov, S., Bulusu, V., Gottlieb, E., & Kamphorst, J. J. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0157-5 · Cited by 29
Bai, C., Hua, J., Meng, D., Xu, Y., Zhong, B., Liu, M., Wang, Z., Zhou, W., Liu, L., Wang, H., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70036 · Cited by 27
Ashraf, A., & Bruce, E. D. (2026) · Antioxidants · doi:10.3390/antiox15030378 · Cited by 29
Biomarkers in renal cell carcinoma: a metabolomics approach
Monteiro, M. S., Carvalho, M. C., Bastos, M. D. L., & de Pinho, P. G. (2014) · Metabolomics · doi:10.1007/s11306-014-0659-5 · Cited by 27
Jhu, J.-W., Yan, J.-B., Lin, Z.-H., Lin, S., & Peng, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189814 · Cited by 28
Karagiota, A., Kanoura, A., Paraskeva, E., Simos, G., & Chachami, G. (2022) · FEBS Journal · doi:10.1111/febs.16694 · Cited by 30
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts
Nwosu, Z. C., Alborzinia, H., Wölfl, S., Dooley, S., & Liu, Y. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00191 · Cited by 27
Fu, X., Guo, X., Wu, S., Lin, Q., Liu, L., Liang, H., Niu, Y., & Li, N. (2019) · Metabolites · doi:10.3390/metabo9090174 · Cited by 27
Glutamine and the Tumor Immune Microenvironment
Faiena, I., Ueno, D., & Shuch, B. M. (2019) · European Urology · doi:10.1016/j.eururo.2019.01.015 · Cited by 27
Jia, N., Ganesan, D., Guan, H., Jeong, Y. Y., Han, S., Rajapaksha, G., Nissenbaum, M., Kusnecov, A. W., & Cai, Q. (2024) · Autophagy · doi:10.1080/15548627.2024.2392408 · Cited by 27
Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets
Oliveira, D. V. N. P., Zhang, S., Chen, X., Calvisi, D. F., & Andersen, J. B. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1292127 · Cited by 26
Li, H., Hurlburt, A. J., & Tennessen, J. M. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035337 · Cited by 27
Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?
Zakhari, S., & Hoek, J. B. (2018) · Cancers · doi:10.3390/cancers10100349 · Cited by 28
Intermediary metabolism: An intricate network at the crossroads of cell fate and function
Ferreira, L. M. R., Li, A. M., Serafim, T. L., Sobral, M. C. M., Alpoim, M. C., & Urbano, A. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165887 · Cited by 27
Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer
Nagayama, Y., & Hamada, K. (2022) · Metabolites · doi:10.3390/metabo12121214 · Cited by 26
Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers
Luise, M. D., Girolimetti, G., Okere, B., Porcelli, A. M., Kurelac, I., & Gasparre, G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.009 · Cited by 28
Girolimetti, G., Guerra, F., Iommarini, L., Kurelac, I., Vergara, D., Maffia, M., Vidone, M., Amato, L. B., Leone, G., Dusi, S., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx186 · Cited by 26
Linehan, W. M. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.022 · Cited by 26
Self-citationPrusinkiewicz, M. A., Tu, J., Dodge, M. J., MacNeil, K. M., Radko-Juettner, S., Fonseca, G. J., Pelka, P., & Mymryk, J. S. (2020) · Viruses · doi:10.3390/v12060610 · Cited by 25
Morad, H. M., Abou‐Elzahab, M. M., Aref, S., & El-Sokkary, A. M. A. (2022) · ACS Omega · doi:10.1021/acsomega.2c00083 · Cited by 25
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
Pang, Y., Lu, T., Xu-Monette, Z. Y., & Young, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065493 · Cited by 28
The dual role of citrate in cancer
Icard, P., Simula, L., Zahn, G., Alifano, M., & Mycielska, M. E. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188987 · Cited by 25
Ambrosini, G., Cordani, M., Zarrabi, A., Alcón-Rodríguez, S., Sainz, R. M., Velasco, G., González‐Menéndez, P., & Dando, I. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01462-0 · Cited by 25
Metabolism in the Tumor Microenvironment
Montenegro, F., & Indraccolo, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_1 · Cited by 26
Chemical Proteomics Reveals Human Off‐Targets of Fluoroquinolone Induced Mitochondrial Toxicity
Reinhardt, T., Harraoui, Y. E., Rothemann, R. A., Jauch, A. T., Müller-Deubert, S. M., Köllen, M. F., Risch, T., Jacobs, L. H. C., Müller, R., Traube, F. R., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202421424 · Cited by 27
Xu, F. L., Ke, X., Hong, M., Huang, M., Chen, C., Tian, X., Hang, H., & Chu, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.024 · Cited by 24
Padinharayil, H., Rai, V., & George, A. (2023) · Cancers · doi:10.3390/cancers15041070 · Cited by 26
Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma
Yeom, K. W., Lober, R. M., Nelson, M. D., Panigrahy, A., & Blüml, S. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1726-0 · Cited by 24
Impaired Mitochondrial Metabolism and Mammary Carcinogenesis
Yadava, N., Schneider, S. S., Jerry, D. J., & Kim, C. G. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9271-3 · Cited by 24
Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes
Pathmanapan, S., Ilkayeva, O., Martin, J. T., Loe, A. K. H., Zhang, H., Zhang, G., Newgard, C. B., Wunder, J. S., & Alman, B. A. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00247-8 · Cited by 25
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
Sarkadi, B., Meszaros, K., Krencz, I., Canu, L., Krokker, L., Zakarias, S., Barna, G., Sebestyen, A., Papay, J., Hujber, Z., et al. (2020) · Cancers · doi:10.3390/cancers12030599 · Cited by 23
Specific regulation of epigenome landscape by metabolic enzymes and metabolites
Yu, X., & Li, S. (2024) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13049 · Cited by 24
Trained Immunity Induced by Oxidized Low‐Density Lipoprotein Is Dependent on Glutaminolysis
Scarpa, A., Jung, Y., Hamid, A., Matzaraki, V., More, T. H., Heinz, A., Groh, L. A., Bekkering, S., Hiller, K., Joosten, L. A. B., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202500802r · Cited by 23
Zhang, J., Duan, H., Feng, Z., Han, X., & Gu, C. (2020) · Oncogenesis · doi:10.1038/s41389-020-0230-3 · Cited by 23
RetractedPharmacologic approaches to amino acid depletion for cancer therapy
Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23
The H+ Transporter SLC4A11: Roles in Metabolism, Oxidative Stress and Mitochondrial Uncoupling
Bonanno, J. A., Shyam, R., Choi, M., & Ogando, D. G. (2022) · Cells · doi:10.3390/cells11020197 · Cited by 23
Ta, N. L., & Seyfried, T. N. (2015) · Lipids · doi:10.1007/s11745-015-4075-z · Cited by 24
Fatica, E. M., DeLeonibus, G. A., House, A., Kodger, J. V., Pearce, R. W., Shah, R., Levi, L., & Sandlers, Y. I. (2019) · Metabolites · doi:10.3390/metabo9120306 · Cited by 26
Torres, M., Elvin, M., Betts, Z., Place, S., Gaffney, C. E., & Dickson, A. J. (2020) · Biotechnology Progress · doi:10.1002/btpr.3099 · Cited by 23
Pérez-Fernández, B. A., Fernández-de-Cossio-Díaz, J., Boggiano-Ayo, T., León, K., & Mulet, R. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27704 · Cited by 23
Metabolic Dysregulation Controls Endocrine Therapy–Resistant Cancer Recurrence and Metastasis
Blundon, M. A., & Dasgupta, S. (2019) · Endocrinology · doi:10.1210/en.2019-00097 · Cited by 23
Hepatic IDH2 regulates glycolysis and gluconeogenesis
Wang, H., Xiong, Q., He, G., Tang, J., Li, S., Cheng, S., Ke, M., Chen, S., Hu, Y., Feng, J., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155559 · Cited by 22
Giallongo, S., Costa, F., Longhitano, L., Giallongo, C., Ferrigno, J., Tropea, E., Vicario, N., Volti, G. L., Parenti, R., Barbagallo, I. A., et al. (2023) · Metabolites · doi:10.3390/metabo13070880 · Cited by 22
Lactate Formation in Primary and Metastatic Colon Cancer Cells at Hypoxia and Normoxia
Graboń, W., Otto‐Ślusarczyk, D., Chrzanowska, A., Mielczarek‐Puta, M., Joniec‐Maciejak, I., Słabik, K., & Barańczyk‐Kuźma, A. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3211 · Cited by 22
Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
Czyzyk-Krzeska, M., Figueroa, J. A. L., Gulati, S., Cunningham, J. T., Meller, J., Shamsaei, B., Vemuri, B., & Plas, D. R. (2021) · Genes · doi:10.3390/genes12030388 · Cited by 23
Zhao, C., Zhang, H., Zhou, J., Lü, Q., Zhang, Y., Yu, X., Wang, S., Liu, R., Pu, Y., & Yin, L. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111997 · Cited by 23
The mechanisms and factors that induce trained immunity in arthropods and mollusks
Zhao, M., Lin, Z., Zheng, Z., Yao, D., Yang, S., Zhao, Y., Chen, X., Aweya, J. J., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1241934 · Cited by 22
Okahashi, N., Kohno, S., Kitajima, S., Matsuda, F., Takahashi, C., & Shimizu, H. (2015) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2015.04.003 · Cited by 22
The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells
Brault, C., & Schulze, A. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_1 · Cited by 22
Flux analysis of inborn errors of metabolism
Reijngoud, D. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0124-5 · Cited by 22
Xu, S., Huo, J., Huang, Y., Aw, M., Chen, S., Mak, S. Y., Yip, L. Y., Ho, Y. S., Ng, S. W., Tan, A. H., et al. (2019) · iScience · doi:10.1016/j.isci.2019.07.002 · Cited by 23
Cheng, G., Pan, J., Podsiadły, R., Zielonka, J., Garces, A. M., Machado, L. G. D. D., Bennett, B., McAllister, D. M., Dwinell, M. B., You, M., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.020 · Cited by 22
Ye, S., Xu, P., Huang, M., Chen, X., Zeng, S., Wang, Q., Chen, J., Li, K., Gao, W., Liu, R., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2499-8 · Cited by 22
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
Sunami, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186799 · Cited by 24
Córdova‐Delgado, M., Fuentes-Retamal, S., Palominos, C., López-Torres, C., Guzmán‐Rivera, D., Ramírez‐Rodríguez, O., Araya‐Maturana, R., & Urra, F. A. (2021) · Antioxidants · doi:10.3390/antiox10101618 · Cited by 22
BACE1 activity impairs neuronal glucose oxidation: rescue by beta-hydroxybutyrate and lipoic acid
Findlay, J. A., Hamilton, D. L., & Ashford, M. L. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00382 · Cited by 22
Han, G., Wei, P., He, M., & He, T. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.3.49 · Cited by 21
NMR Methods for Determining Lipid Turnover via Stable Isotope Resolved Metabolomics
Lin, P., Dai, L., Crooks, D. R., Neckers, L. Μ., Higashi, R. M., Fan, T. W. ‐., & Lane, A. N. (2021) · Metabolites · doi:10.3390/metabo11040202 · Cited by 23
Roma, A., Tcheng, M., Ahmed, N., Walker, S., Jayanth, P., Minden, M. D., Hope, K. J., Rao, P. P. N., Luc, J., Doxey, A. C., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-1032 · Cited by 23
Metadata
- Authors
- Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Northwestern University (US)
- National Institutes of Health (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Chandel, Navdeep S.
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 385-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3262117
- OpenAlex
- W2092152920
- Cited by
- 1,328
- References
- 27
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 63 · 2023: 70 · 2022: 107 · 2021: 107 · 2020: 91 · 2019: 88 · 2018: 82 · 2017: 84 · 2016: 96 · 2015: 98 · 2014: 99 · 2013: 86 · 2012: 80
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA123067, R01CA157996, T32CA009560)
- National Institute of General Medical Sciences (T32GM083831, T32GM008061)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK072565, K01DK078933, DK078933)
- National Center for Research Resources (P41RR002584, RR‐02584)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- reductive carboxylation, glutamine metabolism, IDH1, acetyl-CoA, lipogenesis, hypoxia, tumor growth, fumarate hydratase deficiency, renal carcinoma, TCA cycle
- MeSH terms
- Acetyl Coenzyme A, Animals, Carcinoma, Renal Cell, Electron Transport, Fumarate Hydratase, Glucose, Glutamine, Humans, Isocitrate Dehydrogenase, Kidney Neoplasms, Mitochondria, NADP, Neoplasms, Electron Transport Complex III, Cell Hypoxia, Citric Acid, Electron Transport Complex I, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
